NLM Logo

LAI regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
LAI regimen
Unique ID
C083708
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C083708
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Idarubicin
Frequency
2
Note
chemotherapy protocol consisting of above cpds; used in treatment of acute myelogenous leukemia (AML)
Source
Hematol Oncol 1993 Mar-Apr;11(2):73-80
Date of Entry
1993/11/16
Revision Date
2000/11/30
LAI regimen Preferred
page delivered in 0.004s